Pacific Biosciences of California (PACB) — Strategic Asset Allocation Index
Pacific Biosciences of California (PACB) has a Strategic Asset Allocation Index of 6.3% as of June 2023. Strategic assets (PP&E of $40.32 Million plus long-term investments of $-) total $40.32 Million, measured against net assets of $642.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check PACB financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Pacific Biosciences of California Strategic Asset Allocation Index (2010–2022)
This chart shows how Pacific Biosciences of California's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of June 2023, the index stands at 6.3%, representing strategic assets of $40.32 Million against net assets of $642.00 Million USD. See Pacific Biosciences of California financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Pacific Biosciences of California (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Pacific Biosciences of California from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PACB market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 14.5% | $81.34 Million | $81.34 Million | $- | $562.90 Million | ▲ +4.4 pp |
| 2021 | 10.0% | $79.12 Million | $79.12 Million | $- | $790.99 Million | ▲ +2.6 pp |
| 2020 | 7.4% | $24.90 Million | $24.90 Million | $- | $335.49 Million | ▼ -47.3 pp |
| 2019 | 54.8% | $30.07 Million | $30.07 Million | $- | $54.92 Million | ▲ +24.9 pp |
| 2018 | 29.9% | $34.07 Million | $34.07 Million | $- | $114.06 Million | ▼ -14.2 pp |
| 2017 | 44.0% | $37.92 Million | $37.92 Million | $- | $86.10 Million | ▲ +26.8 pp |
| 2016 | 17.2% | $14.56 Million | $14.56 Million | $- | $84.67 Million | ▲ +5.6 pp |
| 2015 | 11.6% | $8.55 Million | $8.55 Million | $- | $73.54 Million | ▼ -0.4 pp |
| 2014 | 12.0% | $6.60 Million | $6.60 Million | $- | $54.95 Million | ▼ -1.3 pp |
| 2013 | 13.4% | $9.24 Million | $9.24 Million | $- | $69.18 Million | ▲ +0.3 pp |
| 2012 | 13.1% | $14.33 Million | $14.33 Million | $- | $109.38 Million | ▲ +3.5 pp |
| 2011 | 9.6% | $18.40 Million | $18.40 Million | $- | $191.46 Million | ▲ +5.2 pp |
| 2010 | 4.4% | $12.31 Million | $12.31 Million | $- | $279.87 Million | — |